KKR Forms Life Sciences Tools Platform Gamma Biosciences

KKR, a leading global investment firm, today announced the formation of a new platform, Gamma Biosciences (“Gamma” or “the Company”), which will operate a portfolio of companies focused on next-generation bioprocessing technologies for the production of advanced biologic therapies. KKR and co-investors have committed to invest $200 million in Gamma. For KKR, the investment is from its Health Care Strategic Growth Fund, which is focused on high-growth companies for which KKR can be a unique partner in helping reach scale. Gamma recently completed the platform’s first acquisition with its purchase of Astrea Bioseparations, a U.K.-based leader in affinity chromatography and process purification that last month announced a strategic supply partnership with Thermo Fisher Scientific to address the growing demand for better solutions in viral purification for gene therapy.

Read the full article: KKR Forms Life Sciences Tools Platform Gamma Biosciences //

Source: https://www.businesswire.com/news/home/20200218005460/en/KKR-Forms-Life-Sciences-Tools-Platform-Gamma

Scroll to Top